Adenoma
91
4
9
48
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.3%
3 terminated out of 91 trials
94.1%
+7.6% vs benchmark
4%
4 trials in Phase 3/4
15%
7 of 48 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 48 completed trials
Clinical Trials (91)
Does Fluorescence With or Without Indocyanine Green Improve Parathyroid Identification and Preservation
Combination of Artificial Intelligence and Mucosal Exposure Device to Enhance Colorectal Neoplasia Detection
NORCCAP: Norwegian Colorectal Cancer Prevention Trial
Colorectal Cancer Screening in Cystic Fibrosis
Evaluation of 'WAYMED Endo CL CS' for Automated Detection and Diagnosis of Colorectal Adenoma and Non-Adenoma Lesions
Assessing the Additional Neoplasia Yield of Computer-aided Colonoscopy in Follow-up Patients in a Screening Setting
Efficacy of AI-Assisted Colonoscopy for Screening Colorectal Neoplasia (AI-COLOSCREEN)
Six Versus Twelve Month Index Follow-up After Large Colon Polyp Resection
Prevention of Colorectal Cancer Through Multiomics Blood Testing
Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy
Comparison of the ENDOCUFF VISION® Endoscopy Cap Coupled With GI GENIUS™ Artificial Intelligence Compared to Each Device Alone in Improving Colonic Adenoma Detection Rate During Colonoscopy
Evaluation of Early Home Return in Patients With Enucleation of Prostate Adenoma
Care for Colon 2015
R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors
Gastroduodenal Full Thickness Resection Device Registry - gdFTRD® Registry
Synergistic Effect of G-Eye Balloon for Behind the Folds Visualization With CADe (Discovery System) on Adenoma Detection Rate.
Dopamine Agonist Treatment of Non-functioning Pituitary Adenomas
CRC Detection Reliable Assessment With Blood
Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology
Exploratory Study of a Novel Based rbcDNA Liquid Biopsy Technique for Colorectal Cancer Early Detection